Generic Drug Approval Process and Accessibility

Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, testified at a hearing on the accessibility of generic dr… read more

Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, testified at a hearing on the accessibility of generic drugs. She talked about progress being made on reducing the drug application backlog, and efforts to expedite new generic drugs to market.

After the hearing adjourned, Dr. Woodcock spoke informally with reporters for several minutes. close

Report Video Issue

People in this video

More People

Hosting Organization

More information about

Generic Drug Approval Process and Accessibility

795 Views
Program ID:
403817-1
Category:
Senate Committee
Format:
Senate Committee
Location:
Washington, District of Columbia, United States
First Aired:
Jan 28, 2016 | 10:01am EST | C-SPAN 1
Last Aired:
Feb 12, 2016 | 3:11pm EST | C-SPAN 3

Airing Details

  • Jan 28, 2016 | 10:01am EST | C-SPAN 1
  • Jan 28, 2016 | 10:04am EST | C-SPAN 1
  • Jan 28, 2016 | 8:03pm EST | C-SPAN 3
  • Jan 29, 2016 | 2:03am EST | C-SPAN 3
  • Jan 29, 2016 | 4:57pm EST | C-SPAN 3
  • Jan 30, 2016 | 6:21am EST | C-SPAN 2
  • Feb 02, 2016 | 11:46pm EST | C-SPAN 2
  • Feb 12, 2016 | 3:11pm EST | C-SPAN 3
Purchase a Download

Generic Drug Approval Process and Accessibility

  • MP4 video - Standard
    Price:
    $6.99 or Free with MyC‑SPAN
  • MP3 audio - Standard
    Price:
    $0.99

User Created Clips from This Video